Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility

The role of dynamic contrast-enhanced-MRI (DCE-MRI) for Prostate Imaging-Reporting and Data System (PI-RADS) scoring is a controversial topic. In this retrospective study, we aimed to measure the added value of DCE-MRI in combination with T2-weighted (T2W) and diffusion-weighted imaging (DWI) using...

Full description

Bibliographic Details
Main Authors: Valentina Brancato, Giuseppe Di Costanzo, Luca Basso, Liberatore Tramontano, Marta Puglia, Alfonso Ragozzino, Carlo Cavaliere
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/10/3/164
_version_ 1828146433447952384
author Valentina Brancato
Giuseppe Di Costanzo
Luca Basso
Liberatore Tramontano
Marta Puglia
Alfonso Ragozzino
Carlo Cavaliere
author_facet Valentina Brancato
Giuseppe Di Costanzo
Luca Basso
Liberatore Tramontano
Marta Puglia
Alfonso Ragozzino
Carlo Cavaliere
author_sort Valentina Brancato
collection DOAJ
description The role of dynamic contrast-enhanced-MRI (DCE-MRI) for Prostate Imaging-Reporting and Data System (PI-RADS) scoring is a controversial topic. In this retrospective study, we aimed to measure the added value of DCE-MRI in combination with T2-weighted (T2W) and diffusion-weighted imaging (DWI) using PI-RADS v2.1, in terms of reproducibility and diagnostic accuracy, for detection of prostate cancer (PCa) and clinically significant PCa (CS-PCa, for Gleason Score ≥ 7). 117 lesions in 111 patients were identified as suspicion by multiparametric MRI (mpMRI) and addressed for biopsy. Three experienced readers independently assessed PI-RADS score, first using biparametric MRI (bpMRI, including DWI and T2W), and then multiparametric MRI (also including DCE). The inter-rater and inter-method agreement (bpMRI- vs. mpMRI-based scores) were assessed by Cohen’s kappa (κ). Receiver operating characteristics (ROC) analysis was performed to evaluate the diagnostic accuracy for PCa and CS-PCa detection among the two scores. Inter-rater agreement was excellent for the three pairs of readers (κ ≥ 0.83), while the inter-method agreement was good (κ ≥ 0.73). Areas under the ROC curve (AUC) showed similar high-values (0.8 ≤ AUC ≤ 0.85). The reproducibility of PI-RADS v2.1 scoring was comparable and high among readers, without relevant differences, depending on the MRI protocol used. The inclusion of DCE did not influence the diagnostic accuracy.
first_indexed 2024-04-11T20:47:16Z
format Article
id doaj.art-9ed2e7299018496898627a3ece3e18fe
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-04-11T20:47:16Z
publishDate 2020-03-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-9ed2e7299018496898627a3ece3e18fe2022-12-22T04:03:59ZengMDPI AGDiagnostics2075-44182020-03-0110316410.3390/diagnostics10030164diagnostics10030164Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and ReproducibilityValentina Brancato0Giuseppe Di Costanzo1Luca Basso2Liberatore Tramontano3Marta Puglia4Alfonso Ragozzino5Carlo Cavaliere6IRCCS SDN, 80143 Napoli, ItalyOspedale S. Maria delle Grazie, 80078 Pozzuoli, ItalyIRCCS SDN, 80143 Napoli, ItalyIRCCS SDN, 80143 Napoli, ItalyOspedale S. Maria delle Grazie, 80078 Pozzuoli, ItalyOspedale S. Maria delle Grazie, 80078 Pozzuoli, ItalyIRCCS SDN, 80143 Napoli, ItalyThe role of dynamic contrast-enhanced-MRI (DCE-MRI) for Prostate Imaging-Reporting and Data System (PI-RADS) scoring is a controversial topic. In this retrospective study, we aimed to measure the added value of DCE-MRI in combination with T2-weighted (T2W) and diffusion-weighted imaging (DWI) using PI-RADS v2.1, in terms of reproducibility and diagnostic accuracy, for detection of prostate cancer (PCa) and clinically significant PCa (CS-PCa, for Gleason Score ≥ 7). 117 lesions in 111 patients were identified as suspicion by multiparametric MRI (mpMRI) and addressed for biopsy. Three experienced readers independently assessed PI-RADS score, first using biparametric MRI (bpMRI, including DWI and T2W), and then multiparametric MRI (also including DCE). The inter-rater and inter-method agreement (bpMRI- vs. mpMRI-based scores) were assessed by Cohen’s kappa (κ). Receiver operating characteristics (ROC) analysis was performed to evaluate the diagnostic accuracy for PCa and CS-PCa detection among the two scores. Inter-rater agreement was excellent for the three pairs of readers (κ ≥ 0.83), while the inter-method agreement was good (κ ≥ 0.73). Areas under the ROC curve (AUC) showed similar high-values (0.8 ≤ AUC ≤ 0.85). The reproducibility of PI-RADS v2.1 scoring was comparable and high among readers, without relevant differences, depending on the MRI protocol used. The inclusion of DCE did not influence the diagnostic accuracy.https://www.mdpi.com/2075-4418/10/3/164magnetic resonance imagingprostate cancermpmripi-radsdcereproducibilityroc analysis
spellingShingle Valentina Brancato
Giuseppe Di Costanzo
Luca Basso
Liberatore Tramontano
Marta Puglia
Alfonso Ragozzino
Carlo Cavaliere
Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility
Diagnostics
magnetic resonance imaging
prostate cancer
mpmri
pi-rads
dce
reproducibility
roc analysis
title Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility
title_full Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility
title_fullStr Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility
title_full_unstemmed Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility
title_short Assessment of DCE Utility for PCa Diagnosis Using PI-RADS v2.1: Effects on Diagnostic Accuracy and Reproducibility
title_sort assessment of dce utility for pca diagnosis using pi rads v2 1 effects on diagnostic accuracy and reproducibility
topic magnetic resonance imaging
prostate cancer
mpmri
pi-rads
dce
reproducibility
roc analysis
url https://www.mdpi.com/2075-4418/10/3/164
work_keys_str_mv AT valentinabrancato assessmentofdceutilityforpcadiagnosisusingpiradsv21effectsondiagnosticaccuracyandreproducibility
AT giuseppedicostanzo assessmentofdceutilityforpcadiagnosisusingpiradsv21effectsondiagnosticaccuracyandreproducibility
AT lucabasso assessmentofdceutilityforpcadiagnosisusingpiradsv21effectsondiagnosticaccuracyandreproducibility
AT liberatoretramontano assessmentofdceutilityforpcadiagnosisusingpiradsv21effectsondiagnosticaccuracyandreproducibility
AT martapuglia assessmentofdceutilityforpcadiagnosisusingpiradsv21effectsondiagnosticaccuracyandreproducibility
AT alfonsoragozzino assessmentofdceutilityforpcadiagnosisusingpiradsv21effectsondiagnosticaccuracyandreproducibility
AT carlocavaliere assessmentofdceutilityforpcadiagnosisusingpiradsv21effectsondiagnosticaccuracyandreproducibility